CDKN2B-AS1 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma, lincRNA ANRIL was upregulated, and could promote cancer progression by increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells (17).